Trials / Sponsors / Joseph Tuscano
Joseph Tuscano
Academic / Other · 9 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chime Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 2 | 2025-08-07 |
| Recruiting | Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements | Phase 2 | 2025-07-31 |
| Recruiting | Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | 2023-05-24 |
| Recruiting | Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma | Phase 2 | 2020-12-04 |
| Completed | CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymph Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia | Phase 1 | 2020-10-23 |
| Active Not Recruiting | Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma Myeloma | Phase 1 / Phase 2 | 2015-10-01 |
| Unknown | Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma | Phase 2 | 2013-03-12 |
| Completed | Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma Chronic Lymphocytic Leukemia | Phase 2 | 2013-01-14 |
| Completed | Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia Acute Myelogenous Leukemia | Phase 2 | 2012-12-19 |